tetraethylammonium has been researched along with Systemic Vasculitis in 1 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Systemic Vasculitis: A heterogeneous group of diseases characterized by inflammation and necrosis of the blood vessel walls.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BUXTON, R | 1 |
| EICKHOFF, EC | 1 |
1 other study available for tetraethylammonium and Systemic Vasculitis
| Article | Year |
|---|---|
Treatment of thromboangiitis obliterans and thrombophlebitis with tetraethylammonium chloride.
Topics: Humans; Systemic Vasculitis; Tetraethylammonium; Thromboangiitis Obliterans; Thrombophlebitis; Throm | 1948 |